Lazar Spinal Care
- Shockwave Therapy
- Laser Therapy (LLLT)
- Arthritis Treatment
- Migraine Treatment
- Stem Cell Therapy
Ann Arbor, MI
Stem cell therapy listings in Ann Arbor, Michigan sit where orthopedic consults, cash-pay regenerative menus, and research-adjacent practice marketing overlap. Suites near Downtown / Main Street, Kerrytown, and the Huron River corridor use the same three words for very different products. University of Michigan geography is landmark only. This hub is Ann Arbor MI, not Detroit Midtown paste.
"Stem cell" on a menu can mean marrow concentrate, adipose-derived products, perinatal tissue allografts, or something else entirely. FDA status, sourcing, and who injects matter more than the label. Campus-adjacent storefronts are geography only.
This hub lists Directory clinics for Ann Arbor MI and stem cell therapy. Inclusion is not an endorsement. Listing order is not paid ranking. Regenerated.com is free for patients. Featured slots stay labeled; Verified means credential checks, not spend.
Ask what tissue or product is used, how it is sourced and processed, whether imaging guides the injection, who performs the procedure, and what outcomes they track in writing. Prefer plain risk talk. Use the national Stem Cell Therapy Directory and Guide, then return here.
Before you trust badges or counts on this page, read How to read a Regenerated city hub and Featured vs Verified vs organic. Then return here for local listings.
Regulatory context
Michigan cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in Michigan for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. The state has both academic IND research programs and direct-to-patient regenerative clinics.
The FDA has issued warning letters to Michigan clinics offering stem cell and exosome therapies. The Michigan Department of Licensing and Regulatory Affairs can discipline physicians through the Boards of Medicine and Osteopathic Medicine for unprofessional conduct including misleading regenerative medicine advertising. The Michigan Attorney General has pursued enforcement against providers making unsupported clinical claims, though the Smith v Globe Life decision has somewhat narrowed Consumer Protection Act application against licensed professionals. Federal warning letters apply nationally and Michigan clinics that source unapproved cellular products face the same regulatory exposure.
Available here
Nationwide
Stem Cell Therapy clinics across the US